Peptides and Bioregulators
Same peptide. Opposite results. The missing variable is you.
Two people run the identical peptide at the identical dose. One feels like a new body. The other feels wired, flat, or nothing at all. The internet blames the batch. The real difference is almost always the person on the receiving end.
Everyone exploring these compounds is running an experiment. After twenty years mapping where Eastern and Western medicine describe the same body from opposite ends, I help people run it with structure, a sequence matched to their constitution, and guidance, instead of a guess built on forum anecdotes.
Common questions
What exactly is a peptide?
A short chain of amino acids that works as a message. It tells a specific cell to release growth hormone, rebuild tissue, calm inflammation, or switch a gene back on. Your body makes thousands of them. The ones people talk about are copies, or close variations, of those messages.
Read moreWhat's the difference between a peptide and a bioregulator?
Most peptides knock on the outside of a cell, and a receptor passes the message along. Bioregulators are far smaller, two to four amino acids, and are proposed to work inside the cell, switching tissue-specific genes back on. Each one is derived from a specific organ, which is exactly what makes them so interesting.
Read moreAre Ozempic and Wegovy peptides?
Yes. Semaglutide mimics GLP-1, a gut hormone that tells your brain you are full. Millions of people are already on a peptide and never call it that. It is also the clearest picture of the category's power and its limit: it changes the signal without rebuilding the system the signal is sent to.
Read moreAre peptides safe?
Ask it compound by compound. Some have decades of clinical use and a full safety record. Others have promising early data and very little human follow-up. Knowing which is which is half the skill.
Read moreAre peptides legal?
Three categories decide what is possible. FDA-approved drugs, like semaglutide and tirzepatide, are prescribed in the usual way. Some substances may be prepared by compounding pharmacies. Many more sit outside both and are sold as research chemicals. It is moving fast: in July 2026 an FDA advisory committee recommended six compounds, including BPC-157 and TB-500, for the compounding list. FDA has not acted on that yet, so their status is pending. Where a compound has no prescribing pathway, the real question is how to explore it responsibly. That is the gap my coaching fills: I have spent years building direct relationships with trusted sources, so my clients are pointed to high-quality products, including ones a doctor cannot prescribe, with real guidance around them.
Read moreWhich peptide is right for my goal?
The most common question, and the wrong first one. Ask what your body is ready to receive. The same compound lands very differently in different people, and that gap is where the real skill in this field lives.
Read moreCan I trust the seller?
Most people cannot tell, and a good compound from a bad source is still a bad outcome. I have spent years building relationships with trusted suppliers. My team has walked through the labs in person to verify how the products are made, and my team and I test what we recommend independently. A certificate of analysis is a starting point. Direct knowledge of the source is better.
Read moreIs the science real?
It ranges from textbook pharmacology to early-stage research. Semaglutide has large trials behind it. BPC-157 is promising with little human data so far. The Russian bioregulator work spans decades but comes mainly from one institute. I tell you which is which.
Read moreThe categories
Recovery and repair (BPC-157, TB-500)
In Chinese medicine, the Liver governs the smooth flow of Qi and Blood and the health of the tendons, which makes it the organ system of repair. BPC-157 and TB-500 are the two most talked-about compounds for tendons, joints, and soft tissue, usually run together as a stack. Their following comes from athletes and injured people who say they heal in ways nothing else touched.
The human research is still small. One frequently cited study followed twelve people with chronic knee pain, and seven reported relief beyond six months. It is an early signal, and the fact that nearly every source cites that same study tells you how young the human work is.
Weight and metabolic (Semaglutide, Tirzepatide, Retatrutide)
The Spleen, in Chinese medicine, transforms food into usable energy: one of the oldest descriptions of what Western medicine calls metabolism. The GLP-1 family works this exact territory, and it is evolving fast. Semaglutide (Ozempic, Wegovy) acts on one gut hormone. Tirzepatide (Mounjaro, Zepbound) adds a second, GIP, and in trials it improved insulin sensitivity well beyond semaglutide. Retatrutide adds a third, glucagon, which animal studies link to a higher energy burn during weight loss, and it is the newest of the three. In animal work, these drugs also lower ghrelin, the hunger hormone, and a glucagon agonist did too. How much of retatrutide's effect runs through ghrelin has not been measured in people.
These are not appetite pills. They change how the body handles fuel: insulin sensitivity, fat storage, what the body burns for energy. Lean tissue is the cost to watch. In the semaglutide trials, roughly 40 percent of the tissue lost was lean. In the tirzepatide trials it was closer to 25 percent. Retatrutide's glucagon arm is built to keep the body burning fuel instead of slowing down, and in my clients' experience it holds on to muscle best of the three. Published human data on that point are thin, so read it as a directional signal from practice, not a trial result. The compound changes the body. Your constitution decides what kind of change you get.
Mitochondrial and energy (MOTS-c, SS-31)
Chinese medicine places the body's deep reserve, Jing, in the Kidney, along with the fire that turns it into usable energy. Western bioenergetics describes the same conversion inside the mitochondria. MOTS-c is a peptide the mitochondria produce themselves; in animal studies it activates AMPK, the cell's fuel-sensing switch, and protects against diet-related insulin resistance. SS-31 (elamipretide) binds the inner mitochondrial membrane to support the machinery that makes ATP.
They are different tools. MOTS-c is a signal that tells the cell how to adapt to metabolic stress. SS-31 works on the machinery itself, and it has the deeper human record of the pair, with trials in mitochondrial disease and in older adults. The results show who it helps and who it does not, which is the lesson of this whole page again: the same energy problem has different causes in different people.
Immune and thymic (Thymosin Alpha-1, Khavinson thymic peptides)
Chinese medicine describes Wei Qi as the body's defensive boundary, governed by the Lung. Modern immunology locates the maturation of its cellular army, the T-lymphocytes, in the thymus. Read side by side, they describe one defensive system from opposite ends. Thymosin Alpha-1 is approved as a drug in more than 35 countries, though not in the United States.
Khavinson's thymic bioregulators, Thymagen and Vilon, work on the thymus itself, through gene expression rather than receptor signaling. They are the deep end of this category: less famous, and for that reason the part of the map most people have not seen yet.
Cognitive and longevity (Epithalon, Semax, Selank)
Kidney Jing is the constitutional reserve in Chinese medicine: the thing that sets your rhythm, your resilience, and how well you age. Epithalon sits at the center of that idea. It is studied for telomerase activity and sleep regulation, where Kidney Yin's nighttime anchoring meets Heart Shen's daytime clarity. Semax and Selank are the cognitive pair, typically used as nasal sprays because peptides rarely survive digestion.
Reports are mixed. Some users notice nothing from Selank at all. Variability like that is the theme of this whole page: the compound is only half the equation.
Hormonal and signaling (CJC-1295, Ipamorelin, Sermorelin, AOD-9604)
Kidney Qi governs the body's reserve and the rhythm of its signals. Growth hormone secretagogues work the same ground in Western physiology: instead of delivering growth hormone, they prompt your own body to release it in natural pulses. CJC-1295 is on the WADA Prohibited List, which matters only if you compete in tested sport.
Sermorelin has a long clinical history, a USP monograph, and prior FDA approval, and it is now off-patent. That makes it the most accessible compound in this category through compounding channels. AOD-9604, a small fragment of growth hormone studied for fat metabolism, is a different design from the incretins above, and its human weight-loss trials were modest, so it is better thought of as a research compound than a weight-loss tool.
Bioregulators
Bioregulators are the strangest and most interesting corner of this field. They are tiny, two to four amino acids, each derived from a specific organ, and they are proposed to switch back on genes that aging has silenced in that tissue. Organ-specificity is not a side effect. It is the design.
That design is why they line up so well with Chinese medicine, which has organized treatment around organ systems for two thousand years. Most of Western pharmacology works the other way: it picks a receptor and lets the organ effects fall where they fall. Bioregulators start from the organ. Keep reading and you will see what that makes possible.
The terrain problem
Here is the part almost nobody tells you. The same molecule can do different, sometimes opposite, things in different people, and Western science already knows it. Sulforaphane from broccoli, the catechins in green tea, quercetin, curcumin: each has been documented producing different effects depending on how an individual's genes handle it. Biochemical individuality is a measured finding, not a theory.
Now raise the stakes. Peptides are precise enough to speak straight to the endocrine and nervous systems. Run the identical compound at the identical dose in two people, and one feels transformed while the other feels wired, inflamed, and worse. The internet says bad batch. Usually it was not the batch.
Scroll any forum and you will find both people, side by side, arguing. Neither report is wrong. Neither comes with the one thing that would explain it: the constitution of the person writing. A result is only useful once you know whose body it came from.
What differed was the terrain: where each body is already strong, where it breaks down first, how it handles load. Most people optimize the input and never study what is receiving it.
Chinese medicine spent two thousand years doing the second part. It maps those patterns in detail: which organ system leads, which lags, which one is carrying the load. That makes it a practical way to ask what a body is ready for.
Get Your BlueprintPeptides inside the method stack
Peptides are one dimension of eight. Each of the others changes what a peptide signal can do. Sleep, nutrition, and movement shape how much your body can do with a signal at all. Get the surrounding system right and the same compound lands harder. Skip it and even a well-chosen peptide tends to produce a flat or confusing result.
- diagnostics: Which labs and baseline signals should be understood before peptide conversations become meaningful.
- recovery: Repair signals fail when sleep architecture, HRV, and parasympathetic state are not funded.
- nutrition: GLP-1s may change appetite, but nutrition determines metabolic capacity, protein adequacy, and micronutrient sufficiency.
- movement: Repair compounds need a loading signal; tissue remodeling is not passive.
- hormones: Secretagogues and endocrine peptides depend on reserve, rhythm, substrate, and feedback loops.
- breathwork: Immune and inflammatory resilience connect to vagal tone, respiratory capacity, and the Metal/Wei Qi layer.
- mindset: No molecule compensates for a life pattern that keeps the system dysregulated.
Constitutional fit
Here is where two previously separate worlds meet. Western pharmacology usually picks a molecular target and lets organ effects follow. Chinese medicine picks the organ system first and builds treatment around it. Khavinson's bioregulators are the first Western peptide class built the second way: each is derived from a specific organ and aimed back at it. That makes them unusually easy to match against an organ-based map of the body. I came to this from both sides, after two decades inside biophysics, nutrition, and Daoist practice, and the connections on this page are the ones I have spent years working out. They are how I narrow the field for each client before any compound is chosen.
Bronchogen and Thymagen ↔ Lung and Wei Qi
Western medicine treats the lungs and the thymus as separate systems. Chinese medicine files them under one. The Lung governs Wei Qi, the body's defensive boundary, and the thymus is where the cellular army of that boundary, the T-cells, comes to maturity. A bioregulator derived from lung tissue and one derived from the thymus land in the same functional territory, which is why this map pairs them and a conventional protocol would not. The human research is early, which is what makes it a frontier worth watching.
Pancragen ↔ Spleen Qi
Pancragen is derived from pancreatic tissue. In Chinese medicine the Spleen transforms food into usable energy and blood, a job Western biology divides among the pancreas and gut. Insulin, digestive enzymes, glucose handling: the pancreas is the closest single structure to the Spleen's role. The match is functional, not anatomical. Spleen Qi does not mean the organ you can see on a scan.
These are two of the clearest examples from a full organ-by-organ map that covers all five elements. I walk through the whole map with you on a call, matched to your own pattern. One honest note on where the frontier stands: most of the human work on bioregulators comes from a single research institute in St. Petersburg and has not yet been replicated at scale. That is the edge of what is known, and it is why a guide matters.
Book a CallMechanism and evidence depth
Each category works differently. Growth hormone secretagogues prompt your body to release growth hormone in natural pulses. GLP-1 drugs mimic a gut hormone to slow stomach emptying and change appetite. Thymic peptides support T-cell maturation. Bioregulators sit furthest upstream: they are proposed to act inside the cell, reactivating tissue-specific genes at the level of chromatin, with no surface receptor involved.
Strength of evidence varies enormously across these categories, from decades of clinical use to promising early work. I tell you where each one sits, so the compounds with real data are not lumped in with the ones still earning it.
Administration method
How a peptide gets in matters as much as what it is. Most oral peptides are broken down in digestion before they reach the bloodstream, which limits pills to gut-local targets. Semax and Selank are typically used nasally, which is thought to give a more direct route to the brain. Injection remains the standard for systemic and tissue-targeting compounds because absorption is reliable and predictable.
Regulatory status
Three legal categories govern all of this, and most confusion comes from mixing them up. FDA-approved drugs, like semaglutide, tirzepatide, and tesamorelin, have been through full trials and review. Compounding-eligible substances are ones a pharmacy may legally prepare, which requires FDA to have acted formally, not just an advisory committee to have recommended it. Everything else is sold as a research chemical with no established prescribing pathway, and many of the compounds discussed online sit there.
BPC-157 and TB-500 sit in between, and the situation is moving. On July 23-24, 2026, an FDA advisory committee voted to recommend six compounds for the compounding list: BPC-157, TB-500, KPV, MOTS-c, Epitalon, and Semax. It did so against the written recommendation of FDA's own staff, on narrow margins, after every nominating party had already withdrawn its petition. The recommendation is advisory and FDA has not acted on it, so none of these is confirmed compoundable today, and no compounding pharmacy has resumed dispensing them because of it. Worth watching closely.
If you compete in tested sport, WADA's list governs you regardless of anything FDA does. BPC-157, TB-500, MOTS-c, and Epitalon are prohibited at all times, and Semax falls under a separate prohibited category.
Remember whose assessment you are reading. FDA is an interested party in this conversation, not its final authority. The agency has a structural stake in protecting approved-drug revenue, and its briefing documents discount decades of international clinical work, particularly Russian research on compounds like Epitalon and Semax, largely because that work sits outside its jurisdiction and funding structure. Unreplicated in the West is not the same as unsupported.
Vendor trust versus compound skepticism
Two different questions hide inside "is this legit." The first is the seller. Most people cannot tell a good source from a bad one by looking at a website, which is why I spent years building direct relationships with trusted suppliers. My team has walked through the labs in person to verify how the products are made, and my team and I test what we recommend independently. The second is the compound. Real science here runs from decades of clinical use to a handful of early studies from a single lab, and I will tell you which is which and which is worth exploring for you. Keep the two questions separate and you avoid both unearned trust and unearned suspicion.
Peptides are signals. Methods decide whether a signal lands. Your constitution decides the order. Get one of the three wrong and the best compound in the world disappoints.
So skip "which peptide is strongest." Ask what your body is ready to receive right now, and what has to come first if the answer is not yet. That is the question this field has been missing.
It is also why a protocol built on your own constitution beats a thousand forum anecdotes. A stranger's result tells you nothing without knowing whose body produced it. Your blueprint is the missing label.
Still exploring?
Start by goal
Recovery, metabolic health, immune resilience, cognition, or hormonal support.
Start by category
Recovery and repair, weight and metabolic, mitochondrial and energy, immune and thymic, cognitive and longevity, hormonal, or bioregulators.
Start by method
See how each of the eight dimensions of practice changes whether a peptide signal actually lands.
Start by constitution
Understand the Five Elements and how they change sequencing and fit before you look at any one compound.
Start with your own pattern
Take the Five-Element Blueprint and see where you actually stand before choosing anything.